Alcobra Announces Leadership Update
Dr. Yaron Daniely to Step Down as Chief Executive Officer, Effective May 31, 2017
David Baker Named Interim Chief Executive Officer
Dr. Daniely to Remain on Board of Directors and be Appointed Chairman
TEL AVIV, Israel, May 15, 2017 -- (Healthcare... Biopharmaceuticals, Personnel Alcobra, MDX, ADAIR
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Middle East Health | Pharmaceuticals